PA8.F stock +43% pre-market on XETRA 31 Jan 2026: volume surge may continue
PA8.F stock surged 43.00% in pre-market trading on XETRA on 31 Jan 2026, closing the session price at EUR 0.0858 after a high of EUR 0.0858. Trading volume jumped to 17,936 shares versus an average of 850, a relative volume of 21.10. The spike lifted Paion AG (PA8.F) to its year high and placed the tiny market cap of EUR 612,071.00 in focus for short-term traders. We examine drivers, valuation, and forecasts with Meyka AI’s models and a clear trading outlook.
PA8.F stock: price move and immediate drivers
PA8.F stock rose 43.00% pre-market after an intraday range from EUR 0.04 to EUR 0.0858. Volume expanded to 17,936, nearly 21.10x the average, suggesting concentrated buying. The move follows sustained activity since the IPO in July 2023 and a low float of 7,133,700 shares outstanding. Momentum traders cited thin supply and sector chatter in Healthcare as the likely proximate drivers.
PA8.F stock: fundamentals and valuation metrics
Paion AG lists on XETRA in Germany and operates in Drug Manufacturers – Specialty & Generic. The company shows market cap EUR 612,071.00 and no current EPS data. Key ratios include EV/Sales 0.02 and PE -1.06. Revenue per share stands at 4.66, while net income per share is -0.08, reflecting small-scale operations and negative net profit. These metrics point to an early-stage balance sheet and heavy valuation volatility compared with Healthcare peers.
PA8.F stock: technicals, volume, and short-term trading picture
Technical averages are low: 50-day price average EUR 0.01 and 200-day average EUR 0.01. The stock trading at EUR 0.0858 sits well above these moving averages. The day’s wide range and relVolume 21.10 show speculative buying rather than institutional accumulation. Short-term traders should watch intraday support near EUR 0.06 and resistance at today’s high EUR 0.0858.
Meyka AI grade and model forecast for PA8.F stock
Meyka AI rates PA8.F with a score out of 100: 58.75, Grade C+, Suggestion HOLD. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of EUR 0.02. Compared with the current price EUR 0.0858, that implies a model-based downside of -76.64%. Forecasts are model-based projections and not guarantees. We include this grade to frame risk, not as advice.
PA8.F stock: catalysts, risks, and sector context
Catalysts include upcoming earnings announcement on 02 Apr 2026, licensing updates, or clinical progress in anaesthesia products. Risks are thin liquidity, highly volatile micro-cap structure, and limited public financial disclosure. In the German Healthcare sector, average performance is modest, and larger peers show stronger margins. For PA8.F, sector strength alone cannot offset company-level operational risks.
PA8.F stock: trading strategy and price targets
For traders, use tight risk controls given the tiny market cap and volatile swings. Short-term price target: EUR 0.12 (implied upside 39.86% vs EUR 0.0858). Conservative risk scenario aligns with Meyka AI’s monthly forecast at EUR 0.02 (implied downside -76.64%). Reassess after the earnings release on 02 Apr 2026 and any licensed-product news. Link to company filings at Paion AG website and our coverage at Paion AG on Meyka.
Final Thoughts
PA8.F stock’s 43.00% pre-market surge on XETRA on 31 Jan 2026 reflects a volume-driven short-term rally in a micro-cap Healthcare name. The stock trades at EUR 0.0858 with a market cap of EUR 612,071.00, far above its 50- and 200-day averages. Meyka AI rates PA8.F with a score out of 100: 58.75 (Grade C+, Suggestion HOLD). Our models project a short monthly level at EUR 0.02, which implies a downside of -76.64% from today’s price, yet active traders may target EUR 0.12 for a tactical exit. Given thin liquidity, high relative volume, and no confirmed EPS, this remains a high-risk, high-volatility stock. Use strict position sizing, monitor the earnings release on 02 Apr 2026, and treat Meyka AI forecasts as model-based guidance, not guarantees.
FAQs
What caused the PA8.F stock surge today?
The surge was driven by a 43.00% pre-market rise on XETRA with volume at 17,936 shares. The move reflects thin float dynamics and concentrated buying rather than a confirmed fundamental event.
What is Meyka AI’s forecast and grade for PA8.F stock?
Meyka AI rates PA8.F with a score out of 100: 58.75, Grade C+, Suggestion HOLD. The model projects a monthly price of EUR 0.02, a model-based downside of -76.64% from EUR 0.0858.
What price targets should traders use for PA8.F stock?
A tactical short-term target is EUR 0.12 (implied upside 39.86%). A conservative scenario follows the Meyka forecast at EUR 0.02 (implied downside -76.64%). Manage risk tightly.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
